Introduction
Gynecologic laparoscopic surgery increases the risk for postoperative nausea and vomiting (PONV) with an incidence as high as 80% [1] . Pharmacological prophylaxis does not eliminate the incidence of PONV completely and can increase the costs and the risk of adverse events [2] . Supplemental oxygen may be an additional simple method in multimodal PONV prophylaxis. The published data to date remain controversial. Intraoperative FIO 2 of 0.8 was reported as effective as ondansetron prophylaxis in women undergoing general anesthesia for prolonged gynecologic laparoscopic surgery [3] . On the contrary, two reports suggested that perioperative FIO 2 of 0.8 did not prevent PONV after general anesthesia for short ambulatory gynecologic laparoscopic procedures [4, 5] (Table 1) . A factorial trial of six interventions for the prevention of postoperative nausea and vomiting which included mixed general and gynecological surgery found no differences in the incidence of PONV in patients receiving FIO 2 of 0.8 when compared with FIO 2 of 0.3 but the effect of oxygen on early PONV was not analyzed [6] . Recent meta-analysis concluded that FIO 2 of 0.8 compared with FIO 2 of 0.3-0.4 did not reduce PONV after general anesthesia for abdominal and nonabdominal surgery although the early vomiting was significantly reduced in abdominal surgery patients [7] . Nevertheless, studies with patients receiving FIO 2 of 0.5 were excluded from the meta-analysis. FIO 2 of 0.5 is more commonly used in anesthesia practice when higher FIO 2 is desirable. One study found no effect of FIO 2 of 0.5 on PONV in patients undergoing breast surgery but suggested beneficial effect on early postoperative vomiting [8] .
Recent PONV consensus panel concluded that supplemental oxygen had no beneficial effects on PONV. However, this conclusion was based on FIO 2 of 0.8 [9] . There is paucity of data on the influence of FIO 2 of 0.5 on PONV and the effects of oxygen on early and late PONV.
We therefore designed a prospective, randomized, controlled, double blind study to test the hypothesis that high intraoperative oxygen (FIO 2 of 0.5 and FIO 2 of 0.8) compared with routine FIO 2 0.3 reduces the incidence of nausea and vomiting over the initial 24 postoperative hours in women underwent elective gynecological laparoscopic surgery during general anesthesia. The potential for the dose/response effects in reducing the incidence of PONV with higher FIO 2 was evaluated as well.
Methods
After the local ethics committee approval, written informed consent was obtained from 120 adult patients classified as ASA (American Society of Anesthesiologists) physical status I and II, presenting for elective laparoscopic gynecological surgery at General Hospital Zadar, Croatia. The exclusion criteria were as follows: obesity (BMI >30 kg/m²), pulmonary diseases, pregnancy or breast feeding, known hypersensitivity to drugs used in the study protocol, use of antiemetics, psychotropic drugs, hormones and steroids within three days before surgery. Patients with comorbidities that may have an influence on PONV were also excluded, i.e. diseases which impaired gastric motility (diabetes mellitus, chronic cholecystitis, gastric and intestinal disease, neuromuscular disorders, neuropathies and liver dysfunction), vestibular disease, history of migraine headache, central nervous system injury, [10] . Linear trend in reducing the incidence of POV with higher FIO 2 was tested by the Chi squared test for linear trend. Data were expressed as mean values (SD), median and range (minimal and maximal value) or number, percentage and 95% confidence interval (CI). P value of < 0.05 was considered statistically significant.
Results
One hundred and eight of 120 patients, between 21 and 76 years old, completed the study (G30=36, G50=36, G80=36). A total of 12 patients were excluded from the analysis (Figure 1 ). Patients' demographic, intraoperative data and PONV risk scores were not different among the three groups ( Table 2 ). The incidence of early vomiting was significantly decreased with increasing FIO 2 ( Table 3 ). The incidence of vomiting was reduced in groups with supplemental oxygen, G50 and G80, but there was no overall difference among the three groups at 24 hours (Table 3) . Patients with higher oxygen inspiratory fraction had fewer number of vomiting episodes (Table 3 ). There was no difference in severe vomiting G30=5 patients (14%), G50=0 and G80=3(8%), P=0.077. The incidence of nausea was not significantly different among groups, neither for early nor late postoperative period. VAS scores for nausea were not significantly different among groups. There was no difference in the incidence of severe nausea G30=8 (22%), G50=5 (14%) and G80=6 (17%), P=0.639.
Patients received same amount of the rescue antiemetic metoclopramide G30=8 patients (22%), G50=5 (14%) and G80=5 (14%), P=0.549. The VAS pain scores at 2h and 24 hours after surgery were similar among groups ( Table 4 ). Amount of intraoperative opioids and postoperative pain medications were similar among the three groups (Table 4 ). There were no other adverse events reported.
Discussion
Our study suggests that higher intraoperative inspired oxygen fractions FIO 2 0.8 and FIO 2 0.5 in comparison with routine FIO 2 0.3 have no effect on PONV in first 24 hours after gynecologic laparoscopic surgery. FIO 2 of 0.8 as compared with FIO 2 of 0.3 decreases the incidence of early postoperative vomiting, from 22% to 3 %. The number of vomiting episodes was also decreased.
The influence of supplemental perioperative O 2 in laparoscopic gynecological surgery was rarely investigated only in 2 published studies with opposite results [3, 5] . Goll et al. [3] found that FIO 2 of 0.8 when administered during gynecologic laparoscopic surgery halved the incidence of PONV for 24 postoperative hours from 44% to 22% compared with FIO 2 of 0.3.
On the contrary, Purhonen et al. [5] found that perioperative FIO 2 of 0.8 did not reduce the incidence of PONV after ambulatory gynecological laparoscopy, which is in agreement with our findings. That study [5] did not find any difference in early vomiting although the number of patients who vomited in PACU was higher in FIO 2 of 0.3 than in FIO 2 of 0.8 group. The incidence of early vomiting in our study was significantly higher in patients with FIO 2 of 0.3 compared to Purhonen study, 22% vs. 8%, respectively.
Purhonen's group [8] investigated influence of FIO 2 of 0.5 in breast surgery and did not find the difference in PONV compared with FIO 2 of 0.3, 89% vs. 82%, at 24 hours, but the incidence of POV at 2 hours was significantly different, 0% vs. 12%, respectively. In the current study only FIO 2 of 0.8 decreased the incidence of early POV compared with FIO 2 of 0.3 ( Table 3 ). The incidence of early vomiting was decreased as FIO 2 increased. Only one study attempted to correlate the influence of three different intraoperative FIO 2 (0.3, 0.5 and 0.8) on PONV after general anesthesia in breast surgery patients [11] . This study found no difference in the incidence of PONV 24 hours postoperatively, 35% vs. 45% vs. 30%, respectively [11] . However, the decreased incidence of early PONV (30% vs. 20% vs. 10%) with increasing FIO 2 (FIO 2 0.3, FIO 2 0.5 and FIO 2 0.8, respectively) showed similar results.
There appears to be a dose response relationship for early POV. This is suggested by statistically significant linear trend (P=0.01), as tested by the Chi squared test for linear trend, in reducing the incidence of POV with higher FIO 2 (Table 3) . A . larger prospective study would be needed to confirm this relationship.
Recent meta-analysis [7] showed that FIO 2 of 0.8 compared with FIO 2 0.3-0.4 does not decrease incidence of PONV in abdominal and non-abdominal surgery at 24 hours. Early POV was not found to be decreased in non-abdominal surgery, but was decreased in abdominal surgery in the high FIO 2 group. This suggests that the mechanism might be intestinal ischemia and release of short acting metabolites which triggers POV. Although serotonin was suggested as a trigger for POV after abdominal surgery, its role in POV was disputed, since serotonin plasma half life is only few minutes and peaks intraoperatively with no active metabolites postoperatively [7, 12] . FIO 2 of 0.5 was evaluated because it is commonly used in anesthesia practice when higher supplemental oxygen is desired. Use of FIO 2 higher than 0.5 is not without risks [13] [14] [15] [16] [17] .
There were no side effects related to high FIO 2 administration.
There are several limitations to this study. The results may not be generalized to other populations as the results were obtained for only one type of surgery and from a single hospital. The power analysis was calculated according to results of published data but the base incidence was less (44% vs. 36%, respectively) [3] . Therefore, the study may have not enough power to show statistical difference among all groups to avoid type I statistical error.
Assuming the same trend in the incidence of early POV were to persist, a study with sample size of 175 patients in each group would have been necessary to produce a statistically significant difference among each of three groups with a power of 0.8 and α < 0.05. Expected intervention effect of 50% PONV reduction based on two previously published studies in gynecological laparoscopy might to be too optimistic when compared with single antiemetic risk reduction by 26% in a factorial trial of six interventions for the prevention of PONV [3, 5, 6] .
In conclusion, higher intraoperative oxygenation did not reduce the PONV during first 24 hours, however it decreased the incidence of early postoperative vomiting. Therefore, in patients undergoing surgical procedures associated with higher risk of PONV, such as laparoscopic gynecologic surgery, the use of high inspired oxygen concentrations has limited role in preventing the occurrence of this adverse event, and cannot be recommended as a part of routine anti-PONV strategy. 
